A study for a 24 year old woman who takes Monurol - from FDA reports


47 females aged 24 (±5) who take the same drug are studied. This is a personalized study for a 24 year old female patient who has Pancytopenia. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jul, 21, 2018

47 females aged 24 (±5) who take Monurol are studied.


Number of reports submitted per year:

Monurol for a 24-year old woman.

Information of the patient in this study:

  • Age: 24
  • Gender: female
  • Conditions: Pancytopenia
  • Drugs taken:
    • Monurol (fosfomycin tromethamine)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  1. Diarrhea
  2. Nausea and vomiting
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Confusional state
  5. Fatigue (feeling of tiredness)
1 - 6 months:
  1. Type iv hypersensitivity reaction (delayed type hypersensitivity as the reaction takes two to three days to develop)
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Septic shock (shock due to blood infection)
  4. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  5. Toxic skin eruption (skin breakdown due to toxic substance)
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Erythema multiforme (a type of hypersensitivity reaction)
  2. Lupus enteritis (a chronic inflammatory autoimmune disorder that may affect intestines)
  3. Nervousness
  4. Oligohydramnios (a condition in pregnancy characterized by a deficiency of amniotic fluid)
  5. Pain in extremity

Top conditions involved for these people *:

  1. Urinary Tract Infection : 24 people, 51.06%
  2. Cystic Fibrosis (disease of the secretary glands): 5 people, 10.64%
  3. Birth Control : 3 people, 6.38%
  4. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 3 people, 6.38%
  5. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 6.38%

Top co-used drugs for these people *:

  1. Creon (4 people, 8.51%)
  2. Acetaminophen (3 people, 6.38%)
  3. Piperacillin And Tazobactam (3 people, 6.38%)
  4. Acetylcysteine (3 people, 6.38%)
  5. Azithromycin (3 people, 6.38%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!